Alfresa Holdings Corporation (TYO:2784)

Alfresa Holdings Revenue

Alfresa Holdings had revenue of 788.96B JPY in the quarter ending June 30, 2026, with 4.07% growth. This brings the company's total for the last twelve months to 3.13T, up 4.61% year-over-year. In the fiscal year ending March 31, 2026, Alfresa Holdings had annual revenue of 3.10T with 4.83% growth. That makes Alfresa Holdings the 753rd largest company in the world by revenue and 64th in Japan.

• Revenue (ttm): 3.13T
• Revenue Growth: +4.61%
• P/S Ratio: 0.13
• Revenue / Employee: 250.29M
• Employees: 12,525
• Market Cap: 433.89B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Products Wholesale Segment 2.78T 88.6%
• Self-Medication Wholesale Business 267.07B 8.5%
• Pharmaceutical Manufacturing Business 52.18B 1.7%
• Dispensing Pharmacy Business 37.17B 1.2%

Fiscal year ended Mar 31, 2026 See the full Alfresa Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.10T	143.01B	4.83%
Mar 31, 2025	2.96T	102.55B	3.59%
Mar 31, 2024	2.86T	162.43B	6.02%
Mar 31, 2023	2.70T	110.43B	4.27%
Mar 31, 2022	2.59T	-17.53B	-0.67%

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error